India Coronary Stent Market, By Product Type (Drug Eluting Stents, Bare Metal Stents, Bioresorbable Vascular Scaffold), By Material (Cobalt Chromium, Stainless Steel, Platinum Chromium, Nickel Titanium, Polymer), By End User (Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories) is estimated to be valued at US$ 1,303.5 Million in 2023 and is expected to exhibit a CAGR of 13.2 % during the forecast period (2023-2030), as highlighted in a new report published by Coherent Market Insights.
The continuous advent in the field of India coronary stent market is expected to provide lucrative growth opportunities for players. Thus, key market players are focused on adopting growth strategies such as R&D activities, technological advancement related to stents , which will drive the India coronary stent market. For instance, on June 30, 2022 Abbott, a U.S. based medical device company’s xience stent received U.S. Food and drug administration approval for shortest blood thinner course for high bleeding risk patients. Bare-metal and drug-eluting stents show promising clinical outcomes, however, their permanent presence may create complications. In recent years, numerous preclinical and clinical trials have evaluated the properties of bioresorbable stents, including polymer and magnesium-based stents. Three-dimensional (3D) printed-shape-memory polymeric materials enable the self-deployment of stents and provide a novel approach for individualized treatment. Novel bioresorbable metallic stents such as iron- and zinc-based stents have also been investigated and refined.
India coronary stent market– Impact of Coronavirus (COVID-19) Pandemic
The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China) in the last months of 2019 as "coronavirus disease 2019" or COVID-19. This virus spread quickly and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.
COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets.
COVID-19 had a negative impact on the India coronary stent market due to reduced hospital visits by the parients. For instance, according to an article published in journal of chest surgery in 2022, A 37% decrease in surgical case volume was observed during the study period.
India coronary stent market: Key Developments
Increaseing awareness about cardiovascular diseases are expected to drive the growth of India coronary stent market. For instance, in September 29, 2022, Cardiological Society of India launched awareness project on Sudden Cardiac Death on occasion of World Heart Day. With this campaign, The Cardiological Society of India aimed to reach out to 1,00,000 people across India to raise awareness of sudden cardiac mortality where they will provide hands-on Cardio-Pulmonary Resuscitation (CPR) training to more than 10,000 individuals across Delhi, Mumbai, Kolkata, and Chennai.
Browse 19 Market Data Tables and 21 Figures spread through 115 Pages and in-depth TOC on “India coronary stent market”- Forecast to 2030, India Coronary Stents Market, By Product Type (Drug Eluting Stents, Bare Metal Stents, Bioresorbable Vascular Scaffold), By Material (Cobalt Chromium, Stainless Steel, Platinum Chromium, Nickel Titanium, Polymer), By End User (Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories)
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/market-insight/india-coronary-stents-market-3484
Key Takeaways of the India coronary stent market:
The India coronary stent market is expected to exhibit a CAGR of 13.2 % during the forecast period. The cardiovascular heart diseases is expected to grow in the India coronary stent market over the forecast period. For instance, according the World Health Organization, in January 2020, India accounts for one-fifth of these deaths worldwide especially in younger population. The results of Global Burden of Disease study state age-standardized Cardiovascular disease death rate of 272 per 100,000 population in India, which is much higher than that of global average of 235.
Major players operating in the India coronary stent market include Abbott Laboratories, Medtronic, Inc, Biosensors Inc, Terumo Corporation, Boston Scientific Inc., Becton, Dickinson and Company, Cook medicals, B Braun Melsungen AG, SLTL Medical, Endocare, Cardiac Care Products, Invent Bio-med Private Limited, Nano therapeutics pvt ltd, MIV therapeutics.
